Of course not. But like it or not the market sees this as a diminished need for REM-L in treating COIVD-19. REM-L is not a vaccine. It is not competing with vaccines directly, but it is in the respect, that with a majorly successful vaccine there will be diminished cases. As an aside REM-L is also being considered for MIS-C treatment. There is over-lap.
Like it or not the Pfizer announcement has represcussions for the MSB stock price, which over-reacted last night in the US in my opinion. This was an attempt to debunk that as the Pfizer results seem very scant and premature at best. @imback makes some very good relevant points in his post:
https://hotcopper.com.au/threads/msb-trading-2020-a-new-dawn.5553688/page-9949?post_id=48754800
Pfizer announcement, page-11
-
- There are more pages in this discussion • 117 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.0¢ |
Change
-0.005(0.54%) |
Mkt cap ! $1.056B | |||
| Open | High | Low | Value | Volume |
| 92.0¢ | 92.0¢ | 91.5¢ | $245.8K | 267.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 469 | 92.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 16956 | 7 |
View Market Depth
| Last trade - 10.09am 18/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |